Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
- 26 September 2009
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 316 (3), 466-476
- https://doi.org/10.1016/j.yexcr.2009.09.018
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancerInternational Journal of Cancer, 2009
- Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible TranscriptsJournal of Biological Chemistry, 2009
- Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitroJournal of Endocrinology, 2008
- Unconventional Splicing of XBP-1 mRNA in the Unfolded Protein ResponseAntioxidants and Redox Signaling, 2007
- ERα–CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosisOncogene, 2007
- Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomasMolecular and Cellular Endocrinology, 2004
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- The Role of HIF-1α in Transcriptional Regulation of the Proximal Tubular Epithelial Cell Response to HypoxiaJournal of Biological Chemistry, 2003
- Mammalian stanniocalcins and cancer.Endocrine-Related Cancer, 2003
- Molecular Cloning of a Second Human Stanniocalcin Homologue (STC2)Biochemical and Biophysical Research Communications, 1998